Literature DB >> 29927065

DMS-seq for In Vivo Genome-Wide Mapping of Protein-DNA Interactions and Nucleosome Centers.

Taichi Umeyama1,2, Takashi Ito1.   

Abstract

The genome exerts its functions through interactions with proteins. Hence, comprehensive identification of protein-occupied sites by genomic footprinting is critical to an in-depth understanding of genome functions. This unit describes the protocol of dimethyl sulfate-sequencing (DMS-seq). DMS is an alkylating reagent that methylates guanine and adenine in double-stranded DNA. DMS added to the culture medium readily enters the cell and methylates its DNA throughout the genome except for the regions bound by proteins, thereby obviating the need for nuclear isolation in genomic footprinting. Polyamine/AP-endonuclease treatment of DNA isolated from DMS-treated cells induces cleavages at the methylated sites. Deep sequencing of these fragments identifies protein-bound sites as peaks of protected fragments or troughs of cleavage sites. Furthermore, DMS displays an unexpected preference to nucleosome centers, enabling their direct detection without genetic manipulation. Therefore, DMS-seq provides a unique method for non-targeted profiling of in vivo protein-DNA interactions.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  DNA-binding protein; chromatin; epigenome; genomic footprinting

Mesh:

Substances:

Year:  2018        PMID: 29927065     DOI: 10.1002/cpmb.60

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  2 in total

Review 1.  Advances and Trends in Omics Technology Development.

Authors:  Xiaofeng Dai; Li Shen
Journal:  Front Med (Lausanne)       Date:  2022-07-01

2.  Transcription elongation is finely tuned by dozens of regulatory factors.

Authors:  Mary Couvillion; Kevin M Harlen; Kate C Lachance; Kristine L Trotta; Erin Smith; Christian Brion; Brendan M Smalec; L Stirling Churchman
Journal:  Elife       Date:  2022-05-16       Impact factor: 8.713

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.